viropharma inc (VPHM:NASDAQ GS)

Executive Profile*

Background*

Mr. Charles A. Rowland, Charlie, Jr., CPA, MBA, has been the Chief Financial Officer and Vice President at ViroPharma Inc. since October 2008 and served as its Interim Principal Accounting Officer since June 20, 2012. Mr. Rowland is responsible for all areas of finance and accounting, including financial reporting, tax, treasury, and strategic financial planning at ViroPharma. He has over 28 years of diversified experience across a broad field of financial areas. He ... served as the Chief Financial Officer, Executive Vice President and Treasurer of Endo Pharmaceuticals Holdings Inc., from December 6, 2006 to September 2, 2008 and also served as its Co-interim Chief Executive Officer. Mr. Rowland served as Chief Financial Officer and Senior Vice President of Biovail Pharmaceuticals, Inc., a subsidiary of Biovail Corporation. He was responsible for Finance, business direction and activities pertaining to Biovail's operations and administration. He served as Chief Financial Officer and Senior Vice President of Biovail Corporation International from August 2004 to December 2006. Mr. Rowland joined Biovail in July 2004 and has extensive financial and operational experience as a senior member of industry-leading pharmaceutical management teams. Prior to Biovail, he served as Chief Operating and Financial Officer of Breakaway Technologies since 2001 until 2004. He served as Vice President of Finance & IT of Global Pharma Ops. He served four years at Pharmacia Corporation, where he served as Vice President of Finance and Global Supply. Mr. Rowland spent five years at Novartis Pharmaceuticals Corporation, where he served a series of progressively senior positions, including Vice-President of Planning and Decision Support. Prior to 1993, he spent nine years at Bristol-Myers Squibb Company, where he served as Director of Finance. He began his career in 1980 at United Brands Inc. He is a Certified Public Accountant and Member of the American and Pennsylvania Institutes of Certified Public Accountants, and Financial Executives International. Mr. Rowland holds a Master of Business Administration degree in finance from Rutgers University and Bachelor of Science degree in Accounting from the Saint Joseph's University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
VPHM:US	$27.04 USD	+0.60

COMPETITOR COMPENSATION